UBS Group AG - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 15 filers reported holding BENITEC BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$82
+12.3%
3470.0%0.00%
Q1 2023$73
-66.4%
347
-72.8%
0.00%
Q4 2022$217
-98.0%
1,274
-95.6%
0.00%
Q3 2022$11,000
-15.4%
28,683
+140.7%
0.00%
Q2 2022$13,000
+1200.0%
11,916
+3334.0%
0.00%
Q1 2022$1,000
-87.5%
347
-88.8%
0.00%
Q4 2021$8,000
+100.0%
3,106
+192.7%
0.00%
Q3 2021$4,000
+300.0%
1,061
+249.0%
0.00%
Q2 2021$1,000
-87.5%
304
-79.0%
0.00%
Q1 2021$8,000
+700.0%
1,451
+377.3%
0.00%
Q4 2020$1,000
-50.0%
3040.0%0.00%
Q3 2020$2,000
-80.0%
304
-76.7%
0.00%
Q2 2020$10,0001,3020.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$161,4130.01%
Virtu Financial LLC 121,514$260.00%
WealthTrust Axiom LLC 12,950$2,7180.00%
FRANKLIN RESOURCES INC 10,000,000$2,099,0000.00%
Walleye Capital LLC 215,989$45,3360.00%
UBS Group AG 347$730.00%
TWO SIGMA INVESTMENTS, LP 26,747$5,6140.00%
WELLS FARGO & COMPANY/MN 193$410.00%
NORTHERN TRUST CORP 11,813$2,4800.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BENITEC BIOPHARMA INC shareholders